Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

8.76
Delayed Data
As of May 22
 +0.33 / +3.91%
Today’s Change
4.58
Today|||52-Week Range
13.50
+51.03%
Year-to-Date

Today’s Trading

Previous close8.43
Today’s open8.54
Day’s range8.54 - 8.88
Volume22,037
Average volume (3 months)64,605
Market cap$97.2M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-125.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
ITEKInotek Pharmaceutica...+0.06+1.02%
CAPRCapricor Therapeutic...0.000.00%
CRBPCorbus Pharmaceutica...-0.04-1.03%
MNOVMediciNova Inc+0.05+1.25%
Data as of 4:00pm ET, 05/22/2015

Financials

Last reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$9.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers